CanNordic a/s: Financial statements 2015
CVR: 33871902
Source: annual report 2015, Danish Business Authority
01/10/2014 – 30/09/2015
CanNordic a/s (CVR 33871902) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK -83,946 and a net result of DKK -542,410 compared with DKK -39,138 the year before. Equity in the 2015 report amounted to DKK -456,495.
- Gross Profit
- DKK -83,946
- Profit/Loss
- DKK -542,410
- Equity
- DKK -456,495
- Total Assets
- DKK 1,938,528
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | -84 t. | -542 t. | -456 t. | - |
| 2014 | - | 159 t. | -39 t. | 86 t. | - |
| 2013 | - | 325 t. | 89 t. | 125 t. | - |
Official annual report
How creditworthy is CanNordic a/s?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
CanNordic a/s has published its annual report for 2014. Gross profit came to DKK 158,882, and the net result was DKK -39,138.
About CanNordic a/s
CanNordic a/s is a Danish company of the type Aktieselskab based in København Ø, founded in 2011. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named GALAXA PHARMA ApS. The management consists of Lone Henriksen. The board consists of Gitte Henriksen, Jens Jørgen Hagelskjær and Lone Henriksen. The company is owned by CS MEDICA a/s. The company has 4 employees (2026). In 2025, the company reported a gross profit of DKK -100,395 and a net result of DKK -6,219,720 compared with DKK -4,881,640 the year before. Equity in the 2025 report amounted to DKK 4,298,968.